Improving Medication Safety in the Perioperative Setting

 A Midday Symposium conducted at the 49th ASHP Midyear Clinical Meeting and Exhibition

Wednesday, December 10, 2014 - 11:30am-1:00pm PST
Hilton Anaheim, Pacific Ballroom D
Click here to register

Overview

The perioperative (operating room) environment is a high-risk, complex area where medication errors lead to disproportionately more harm than errors elsewhere in the hospital. This symposium will focus on current issues in perioperative medication safety and ways to prevent harmful adverse drug events. Leading national experts will address often unrecognized problems, discuss actual cases where errors have occurred, outline relevant regulatory and/or accreditation requirements, and provide a description of how one organization has successfully implemented risk reduction strategies in the surgical setting. A question and answer session will allow participants to gather additional input on challenges that arise in clinical practice.

Objectives

The target audience for this activity includes pharmacists in health-system settings. At the completion of this symposium, the participant should be able to:

• Describe how medications are ordered, stored, prepared, and utilized in the perioperative setting.
• Identify system-based causes of medication errors associated with the use of medications in the perioperative setting.
• Describe current regulatory and accreditation requirements related to perioperative medication safety.
• Describe practical approaches currently used by hospitals and health systems to improve medication safety.
• Prioritize selected strategies to prevent harm and improve medication safety in the surgical setting.

Agenda

10:45am - Doors Open
11:30am-1:00pm - Symposium
Space is limited and pre-registration is encouraged. Pre-registration is for planning purposes only and seating will be available on a first-come, first-served basis.

Food and beverage are no longer provided at Midday Symposia. This ASHP policy considers the varied internal policies of commercial supporters related to the Physician Payments Sunshine Act. You are welcome to bring your lunch to the session.

Topics and Faculty

Introduction and Program Overview
Michael R. Cohen, RPh, MS, ScD, FASHP, President, ISMP

A Primer on Medication Use in the Operating Room Suite
Michelle Mandrack, RN, MSN, Director of Consulting Services, ISMP

Practices that Can Improve Medication Safety in the Perioperative Setting
Darryl S. Rich, PharmD, MBA, FASHP, Medication Safety Specialist, ISMP

Practical Approaches to Implementing Medication Safety
Strategies in the Perioperative Setting
Elizabeth A. Wade, PharmD, BCPS, Medication Safety Officer,
Concord Hospital, Concord, NH

CE Accreditation

Pharmacists

This CE activity is jointly provided by ProCE, Inc. and the Institute for Safe Medication Practices (ISMP). ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-14-233-L05-P has been assigned to this knowledgebased live CE activity (initial release date December 10, 2014). This CE activity is approved for 1.5 contact hours (0.15 CEUs) in states that recognize ACPE providers. This CE activity is provided at no cost to participants. Successful completion of the online post-test and evaluation at www.ProCE.com no later than January 9, 2015 is required to receive CE credit. CE credit will be automatically uploaded to NABP/CPE Monitor within 1 to 2 weeks of the completion of the post-test and evaluation. No partial credit will be given.

Disclosure

It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed during their presentation. Dr. Cohen has no relevant commercial or financial relationships to disclose. Ms. Mandrack has no relevant commercial or financial relationships to disclose. Dr. Rich has no relevant commercial or financial relationships to disclose. Dr. Wade has no relevant commercial or financial relationships to disclose.

Please note: The opinions expressed in this activity should not be construed as those of the CE provider. The information and views presented in this activity are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include the use of drugs and/or devices for unlabeled indications, which should be considered experimental. Participants are advised to consult manufacturer product information and the professional literature, and use professional judgment in applying the presented information in patient-care activities.

Funding

This symposium is funded through an educational grant from Eagle Pharmaceuticals.